Abstract
Background The advent of genetic biobanking has powered gene-environment interaction (GxE) studies in various disease contexts. Therefore, we aimed to discover novel GxE effects that address hot spring residency as a risk to inconspicuous disease association.
Methods A complete genetic and demographic registry comprising 129,451 individuals was obtained from Taiwan Biobank (TWB). Geographical disease prevalence was analyzed to identify putative disease association with hot-spring residency, multivariable regression and logistic regression were rechecked to exclude socioeconomic confounders in geographical-disease association. Genome-wide association study (GWAS), gene ontology (GO), and protein-protein interaction (PPI) analysis identified predisposing genetic factors among hotspring-associated diseases. Lastly, a polygenic risk score (PRS) model was formulated to stratify environmental susceptibility in accord to their genetic predisposition.
Results After socioeconomic covariate adjustment, prevalence of dry eye disease (DED) and valvular heart disease (VHD) was significantly associated with hot spring distribution. Through single nucleotide polymorphisms (SNPs) discovery and subsequent PPI pathway aggregation, CDKL2 and BMPR2 kinase pathways were significantly enriched in hot-spring specific DED and VHD functional SNPs. Notably, PRS predicted disease well in hot spring regions (PRSDED: AUC=0.9168; PRSVHD AUC=0.8163). Hot spring and discovered SNPs contributed to crossover GxE effect on both DED (relative risk (RR)G+E-=0.99; RRG+E+=0.35; RRG+E+=2.04) and VHD (RRG+E-=0.99; RRG+E+=0.49; RRG+E+=2.01).
Conclusion We identified hot-spring exposure as a modifiable risk in the PRS predicted GxE context of DED and VHD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Taiwan National Science and Technology Council [grant numbers NSTC 112-2321-B-A49-007, NSTC 111-2320-B-A49-028-MY3, NSTC 112-2124-M-038-001, and NSTC 112-2314-B-032-001]; and Taipei Veterans General Hospital [grant number V113C-201, V112C-026 and 112VACS-007].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Taipei Veterans General Hospital gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
